home / stock / germ / germ news


GERM News and Press, ETFMG Treatments Testing and Advancements From 03/26/24

Stock Information

Company Name: ETFMG Treatments Testing and Advancements
Stock Symbol: GERM
Market: NYSE

Menu

GERM GERM Quote GERM Short GERM News GERM Articles GERM Message Board
Get GERM Alerts

News, Short Squeeze, Breakout and More Instantly...

GERM - ETFMG Treatments, Testing and Advancements ETF declares quarterly distribution of $0.0558

2024-03-26 09:14:45 ET More on ETFMG Treatments, Testing and Advancements ETF Dividend scorecard for ETFMG Treatments, Testing and Advancements ETF Read the full article on Seeking Alpha For further details see: ETFMG Treatments, Testing and Advancements ETF decl...

GERM - Amplify ETFs Declares March Income Distributions for its ETFs

CHICAGO, March 26, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announces March income distributions for its ETFs. About Amplify ETFs Amplify ETFs, sponsored by Amplify Investments, has over $9.1 billion in assets across its suite of ETFs (as of 1/26/2024). Amplify ETFs deliver expanded ...

GERM - Taking Stock: Q2 2024 Equity Market Outlook

2024-03-22 11:15:00 ET Summary A positive January for U.S. stocks is typically a prelude to a positive year, with our analysis finding the correlation to hold 80% of the time since 1928. Stocks look well-positioned to outperform bonds and cash again this year, but high valuations ...

GERM - 2024 Outlook: A New 'Super Boom'? Or Chop And Churn?

2024-03-13 10:10:00 ET Summary Jeff Hirsch, editor-in-chief of The Stock Trader’s Almanac, and Carter Worth, CEO and founder of Worth Charting, discuss their outlook for 2024 with MoneyShow's Mike Larson. Jeff expects a strong year for stocks, with gains of 8-15% broadly sp...

GERM - Why Biotech Stocks May Be Ready For A Recovery

2024-03-09 03:59:00 ET Summary Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a healthy recovery. Biot...

GERM - Sector Insights: What Could Go Right In 2024?

2024-02-23 04:05:00 ET Summary Within healthcare, an area that has been negatively impacted the last couple of years is the pharmaceutical manufacturing value chain. Several capital goods and materials sectors experienced recessionary conditions last year, which caused weak fundam...

GERM - Barbell Equity Exposure In '24

2024-01-31 04:36:00 ET Summary 2023 was characterized by narrow leadership and multiple expansions. While last year’s gains have led to headline valuations appearing stretched, there are many segments of the market that are not as aggressively priced. With the expectati...

GERM - Amplify ETFs Completes Acquisition to Reach $9.1 Billion AUM Across 31 ETFs

CHICAGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announced today it has completed its previously announced acquisition of ETF Managers Group (ETFMG) exchange-traded fund (ETF) assets, which consist of over $3.7 billion of assets under management (AUM) across 14 ETFs (as of 1/26/2024). Ampl...

GERM - Sectors To Watch With Potential Rate Cuts On The Horizon

2024-01-16 04:50:00 ET Summary Why US banks could be poised for a rebound? Sectors primed for a pivot if the Fed cuts. The outlook for healthcare and real estate. The potential for interest rate cuts this year by the U.S. Federal Reserve is raising the outlook for ...

GERM - Investing Themes For 2024

2024-01-15 12:40:00 ET Summary All decisions around investing, everything we're seeing everyone doing is now colored by the rate situation. Artificial intelligence is a constantly growing and transforming phenomenon. Unlike artificial intelligence, a lot of the most exciting a...

Previous 10 Next 10